Morgan Stanley Co Diagnostics, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 5,962 shares of CODX stock, worth $1,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,962

Previous 21,801 72.65%

Holding current value

$1,490

Previous $16,000 93.75%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.31 - $1.0 $4,910 - $15,839	-15,839 Reduced 72.65%	5,962 $1,000
Q4 2024 Feb 14, 2025	BUY	$0.7 - $1.36 $5,084 - $9,879	7,264 Added 49.97%	21,801 $16,000
Q3 2024 May 14, 2025	SELL	$1.02 - $1.75 $5,784 - $9,924	-5,671 Reduced 28.06%	14,537 $18,000
Q3 2024 Nov 14, 2024	SELL	$1.02 - $1.75 $5,784 - $9,924	-5,671 Reduced 28.06%	14,537 $18,000
Q2 2024 May 14, 2025	SELL	$1.01 - $1.7 $1,608 - $2,708	-1,593 Reduced 7.31%	20,208 $25,000
Q2 2024 Oct 17, 2024	BUY	$1.01 - $1.7 $3,049 - $5,132	3,019 Added 17.56%	20,208 $25,000
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.7 $3,049 - $5,132	3,019 Added 17.56%	20,208 $25,000
Q1 2024 Oct 17, 2024	SELL	$1.06 - $1.42 $3,200 - $4,286	-3,019 Reduced 14.94%	17,189 $19,000
Q1 2024 Aug 16, 2024	SELL	$1.06 - $1.42 $1,656 - $2,219	-1,563 Reduced 8.34%	17,189 $19,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.42 $1,656 - $2,219	-1,563 Reduced 8.34%	17,189 $19,000
Q4 2023 Aug 16, 2024	SELL	$1.0 - $1.5 $1,456 - $2,184	-1,456 Reduced 7.21%	18,752 $24,000
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.5 $1,837 - $2,755	-1,837 Reduced 8.92%	18,752 $24,000
Q3 2023 Nov 15, 2023	SELL	$1.03 - $1.85 $8,276 - $14,864	-8,035 Reduced 28.07%	20,589 $21,000
Q2 2023 Aug 14, 2023	SELL	$1.04 - $1.64 $512,318 - $807,886	-492,614 Reduced 94.51%	28,624 $31,000
Q1 2023 May 15, 2023	BUY	$1.39 - $3.24 $214,105 - $499,066	154,033 Added 41.95%	521,238 $771,000
Q4 2022 Feb 14, 2023	SELL	$2.32 - $3.68 $28,883 - $45,816	-12,450 Reduced 3.28%	367,205 $925,000
Q3 2022 Nov 14, 2022	SELL	$2.87 - $7.01 $362,214 - $884,711	-126,207 Reduced 24.95%	379,655 $1.22 Million
Q2 2022 Oct 27, 2022	BUY	$3.76 - $6.29 $1.81 Million - $3.02 Million	480,532 Added 1897.09%	505,862 $2.84 Million
Q2 2022 Aug 15, 2022	BUY	$3.76 - $6.29 $1.81 Million - $3.02 Million	480,532 Added 1897.09%	505,862 $2.84 Million
Q1 2022 Oct 27, 2022	SELL	$5.03 - $9.61 $2.42 Million - $4.62 Million	-480,532 Reduced 94.99%	25,330 $156,000
Q1 2022 May 13, 2022	SELL	$5.03 - $9.61 $207,834 - $397,075	-41,319 Reduced 61.99%	25,330 $156,000
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $573,702 - $732,671	-70,653 Reduced 51.46%	66,649 $596,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $1.03 Million - $1.56 Million	137,302 New	137,302 $1.34 Million

Others Institutions Holding CODX

# of Institutions

Shares Held

5.71M

Call Options Held

35.6K

Put Options Held

25.9K

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $8.45M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account